Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

PostScript

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Free

Authors

Tamera Jo Corte Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, AustraliaUniversity of Sydney, Sydney, New South Wales, Australia PubMed articles Google scholar articles
Nicole S Goh Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Ian N Glaspole Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Christopher J Zappala Department of Respiratory Medicine, Royal Brisbane Hospital, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Peter M Hopkins Department of Pulmonary Transplantation and Vascular Medicine, Prince Charles Hospital, Brisbane, Queensland, Australia PubMed articles Google scholar articles
Margaret L Wilsher Department of Respiratory Medicine, Auckland Hospital, Auckland, New Zealand PubMed articles Google scholar articles

Correspondence to Dr Tamera Jo Corte, Department of Respiratory Medicine, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia; tameracorte{at}mac.com

Citation

Corte TJ, Goh NS, Glaspole IN, et al

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Thorax 2013;68:491-492.

Publication history

Received December 9, 2012
Accepted December 17, 2012
First published January 23, 2013.

Online issue publication

April 12, 2013

Article Versions

Previous version (23 January 2013).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions